Guillermo Izquierdo

Guillermo Izquierdo

UNVERIFIED PROFILE

Are you Guillermo Izquierdo?   Register this Author

Register author
Guillermo Izquierdo

Guillermo Izquierdo

Publications by authors named "Guillermo Izquierdo"

Are you Guillermo Izquierdo?   Register this Author

100Publications

3792Reads

35Profile Views

Splice-site variant in ACSL5: a marker promoting opposing effect on cell viability and protein expression.

Eur J Hum Genet 2019 May 3. Epub 2019 May 3.

Department of Cell Biology and Immunology, Instituto de Parasitología y Biomedicina "López Neyra" (IPBLN), Consejo Superior de Investigaciones Científicas (CSIC), 18016, Granada, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41431-019-0414-5DOI Listing
May 2019

Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy.

J Neurol Sci 2018 08 2;391:72-76. Epub 2018 Jun 2.

Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia; Department of Neurology, Alfred Hospital, Melbourne, VIC, Australia; Box Hill Hospital, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2018.06.001DOI Listing
August 2018

Cross-cultural adaptation and validation of the VISA-A questionnaire for Chilean Spanish-speaking patients.

J Orthop Surg Res 2018 Jul 13;13(1):177. Epub 2018 Jul 13.

Centre for Sports and Exercise Medicine, Barts and The London School of Medicine and Dentistry, Mile End Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13018-018-0882-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045880PMC
July 2018

Multiple sclerosis symptoms and spasticity management: new data.

Neurodegener Dis Manag 2017 Nov;7(6s):7-11

Department of Neurology, Hospital Universitario Virgen Macarena, Avenida Doctor Fedriani, 3, 41009, Seville, Spain.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/nmt-2017-0034
Publisher Site
http://dx.doi.org/10.2217/nmt-2017-0034DOI Listing
November 2017

Dynamic regulation of serum aryl hydrocarbon receptor agonists in MS.

Neurol Neuroimmunol Neuroinflamm 2017 Jul 16;4(4):e359. Epub 2017 Jun 16.

Ann Romney Center for Neurologic Diseases (V.R., D.M.B., M.A.M., C.C.H., K.R., A.P., P.K., R.B., H.L.W., F.J.Q.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Molecular Biology Service and MS Unit (M.I.G.S., G.I.), University of Seville, Spain; and Broad Institute of MIT and Harvard (F.J.Q.), Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000359DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473958PMC
July 2017

Study of the anti-JCV antibody levels in a Spanish multiple sclerosis cohort.

Eur J Clin Invest 2017 Feb;47(2):158-166

Neurology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/eci.12721DOI Listing
February 2017

Clinical and arthrometric outcomes of an anatomic outside-in single-bundle anterior cruciate ligament reconstruction using a retrodrill.

Knee 2016 Dec 2;23(6):1098-1105. Epub 2016 Nov 2.

The Knee Surgery Unit, Orthopaedics and Traumatology Department, Clínica Alemana - Universidad del Desarrollo, Santiago, Chile.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.knee.2016.07.007DOI Listing
December 2016

The multiple sclerosis-associated regulatory variant rs10877013 affects expression of CYP27B1 and VDR under inflammatory or vitamin D stimuli.

Mult Scler 2016 07 14;22(8):999-1006. Epub 2015 Oct 14.

Department of Cell Biology and Immunology, Instituto de Parasitología y Biomedicina "López Neyra" (IPBLN-CSIC), Granada, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458515610208DOI Listing
July 2016

Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.

Neurol Clin Pract 2016 Apr;6(2):102-115

Department of Medicine and Melbourne Brain Centre at the Royal Melbourne Hospital (TS, TK, VJ, HB), University of Melbourne, Australia; Biogen Idec Inc. (AZ, FP, SB, RH), Cambridge, MA; Department of Neurology (HW), University of Münster, Germany; Groene Hart Ziekenhuis (FV), Gouda, the Netherlands; MS Center, Department of Neuroscience, Imaging and Clinical Sciences (AL), University "G. d'Annunzio," Chieti, Italy; MS Center, Department of Neurology, First Medical Faculty (EH, DH), Charles University, Prague, Czech Republic; Center de Réadaptation Déficience Physique Chaudière-Appalache (PG), Levis; Hôpital Notre Dame (PD, AP), Montreal, Canada; Ospedali Riuniti di Salerno (G. Iuliano), Salerno, Italy; 19 Mayis University (M. Terzi), Medical Faculty, Turkey; Hospital Universitario Virgen Macarena (G. Izquierdo), Sevilla, Spain; Orbis Medical Centre (RMMH), Sittard-Geleen, the Netherlands; KTU Medical Faculty Farabi Hospital (CB), Trabzon, Turkey; Neurology Unit (EP, GG), ASUR Marche-AV3, Macerata; Nuovo Ospedale Civile S. Agostino (PS), Modena; AORN San Giuseppe Moscati (DLAS), Avellino, Italy; John Hunter Hospital (JL-S), Newcastle, Australia; Neurological Institute IRCCS Mondino (RB), Pavia, Italy; Neuro Rive-Sud (F. Grand'Maison), Hôpital Charles LeMoyne, Quebec, Canada; University of Parma (F. Granella), Italy; Department of Neurology (LK), University Hospital Basel, Switzerland; Department of Basic Medical Sciences, Neuroscience and Sense Organs (M. Trojano), University of Bari, Italy; and Department of Neurology (HB), Eastern Health, Monash University, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/CPJ.0000000000000227DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828679PMC
April 2016

Genome-wide significant association with seven novel multiple sclerosis risk loci.

J Med Genet 2015 Dec 16;52(12):848-55. Epub 2015 Oct 16.

Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany Department of Medicine, School of Public Health, Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmedgenet-2015-103442DOI Listing
December 2015

Long-term epidemiology of multiple sclerosis in the Northern Seville District.

Acta Neurol Scand 2015 Aug 4;132(2):111-7. Epub 2015 Feb 4.

Unidad de Esclerosis Múltiple, Servicio de Neurología, Hospital Universitario Virgen Macarena, Sevilla, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ane.12363DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024007PMC
August 2015

Clinical case reviews and poster sessions in multiple sclerosis spasticity: main outcomes and highlights.

Eur Neurol 2014 26;72 Suppl 1:15-9. Epub 2014 Sep 26.

Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Bari, Italy.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/367619
Publisher Site
http://dx.doi.org/10.1159/000367619DOI Listing
June 2015

Effectiveness of glatiramer acetate compared to other multiple sclerosis therapies.

Brain Behav 2015 Jun 1;5(6):e00337. Epub 2015 May 1.

Chair of Health Economics and Rational Drug Use, School of Medicine, University of Málaga Boulevard Louis Pasteur, 32, 29071, Málaga, Spain ; Department of Pharmacology and Clinical Therapeutics, School of Medicine, University of Málaga Boulevard Louis Pasteur, 32, 29071, Málaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/brb3.337DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467772PMC
June 2015

Comparative efficacy of switching to natalizumab in active multiple sclerosis.

Ann Clin Transl Neurol 2015 Apr 27;2(4):373-87. Epub 2015 Feb 27.

Department of Medicine and Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne Melbourne, Australia ; Department of Neurology, Eastern Health, Monash University Box Hill, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acn3.180DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402083PMC
April 2015

Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis.

Neurology 2015 Mar 30;84(9):872-9. Epub 2015 Jan 30.

From the University Hospital Basel (L.K., M.M.), Basel, Switzerland; Hospital Clínico San Carlos (R.A.), Madrid, Spain; Virgen Macarena Hospital (G.I.), Seville, Spain; Medical University of Lodz (K.S.), Lodz, Poland; Novartis Pharmaceuticals Corporation (V.C.-P.), Hanover, NJ; Novartis Pharma AG (A.K., P.v.R.), Basel, Switzerland; and Novartis Healthcare Pvt. Ltd. (M.B., A.S.), Hyderabad, India.

View Article

Download full-text PDF

Source
http://www.neurology.org/content/early/2015/01/30/WNL.000000
Web Search
http://www.neurology.org/cgi/doi/10.1212/WNL.000000000000130
Publisher Site
http://dx.doi.org/10.1212/WNL.0000000000001302DOI Listing
March 2015

A pragmatic approach to dealing with fingolimod-related lymphopaenia in Europe.

Mult Scler Relat Disord 2015 Jan 13;4(1):83-4. Epub 2014 Oct 13.

Department of Laboratory Medicine, Stem Cell Center, Lund University, Sweden; Department of Hematology, Skåne University Hospital, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2014.09.215DOI Listing
January 2015

Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles.

Neurol Neuroimmunol Neuroinflamm 2014 Dec 11;1(4):e47. Epub 2014 Dec 11.

Department of Immunology (B.d.l.H., E.U., A.G.V.) and Department of Neurology, Multiple Sclerosis Unit (R.A.), Hospital Clínico San Carlos (IdISSC), Madrid, Spain; Pole des neurosciences et INSERM U1043 (D.B.), Université de Toulouse III, Hopital Purpan, Toulouse, France; Department of Neurology (A.C., A. Salmen), St. Josef-Hospital, Ruhr University, Bochum, Germany; Servei de Neurologia-Neuroimmunologia (A.V.-J., S.M., N.F., A.H., X.M., M.C.), Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Spain; Departments of Neurology and Immunology (L.M.V., J.C.A.-C.), Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigacion Sanitaria, Madrid, Spain; Hospital Universitario Virgen Macarena (G.I.), Seville, Spain; Unidad de Gestión Clínica de Neurociencias (O.F., B.O.), Instituto de Biomedicina de Málaga (IBIMA), Hospital Universitario Regional de Málaga, Universidad de Málaga, Spain; Service of Neurology (A. Saiz), Hospital Clínic, Universitat de Barcelona and Institut d´Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Biochemistry, Molecular and Cellular Biology (J.R.A.), Science Faculty, University of Zaragoza, Spain; and Fundación de Investigación Biomédica (V.M.), Hospital Universitario de la Princesa, Madrid, Spain.

View Article

Download full-text PDF

Source
http://nn.neurology.org/lookup/doi/10.1212/NXI.0000000000000
Publisher Site
http://dx.doi.org/10.1212/NXI.0000000000000047DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268037PMC
December 2014

Disentangling the attention network test: behavioral, event related potentials, and neural source analyses.

Front Hum Neurosci 2014 13;8:813. Epub 2014 Oct 13.

Psychophysiology Unit (Lab B508), Department of Experimental Psychology, Faculty of Psychology, University of Seville Seville, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fnhum.2014.00813DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195286PMC
October 2014

Fingolimod after natalizumab and the risk of short-term relapse.

Neurology 2014 Apr 7;82(14):1204-11. Epub 2014 Mar 7.

From the Department of Medicine (V.G.J., T.K., H.B.), Melbourne Brain Centre (RMH), The University of Melbourne; Department of Neurology (V.G.J., V.L., T.K., H.B.), Royal Melbourne Hospital, Australia; Hospital Universitario Virgen Macarena (G.I.), Seville, Spain; Liverpool Hospital (S.H.), New South Wales, Australia; Amiri Hospital (R.A.), Kuwait City, Kuwait; John Hunter Hospital (J.L.-S.), Newcastle, Australia; MS Center (A.L.), Department of Neuroscience and Imaging, University "G. d'Annunzio," Chieti, Italy; Hôpital Notre Dame (P.D., M.G.), Montreal, Canada; Brain and Mind Research Institute (M.B.), Sydney, Australia; Neuro Rive-Sud (F.G.), Hôpital Charles LeMoyne, Quebec, Canada; Department of Basic Medical Sciences (M.T.), Neuroscience and Sense Organs, University of Bari, Italy; Flinders University and Medical Centre (M.S.), Adelaide, Australia; Ospedale di Macerata (G.G.), Italy; Geelong Hospital (C.S.), Australia; Karadeniz Technical University (C.B.), Trabzon, Turkey; AORN San Giuseppe Moscati (D.L.A.S.), Avellino, Italy; Groene Hart Ziekenhuis (F.V.), Gouda, the Netherlands; Department of Neurology (J.H., H.B.), Eastern Health Victoria; Monash University (J.H., H.B.), Melbourne; and Melbourne EpiCentre (D.L.), The University of Melbourne and Melbourne Health, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000000283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001200PMC
April 2014

Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS.

J Neurol 2013 Aug 30;260(8):2023-32. Epub 2013 Apr 30.

Mellen Center U-10, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-013-6932-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3737385PMC
August 2013

TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis.

Neurology 2013 May 26;80(22):2010-6. Epub 2013 Apr 26.

Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya, Cemcat, Hospital Universitari Vall d´Hebron, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0b013e318294b2d6DOI Listing
May 2013

Aquaporins, anti-aquaporin-4 autoantibodies and neuromyelitis optica.

Clin Chim Acta 2013 Jan 2;415:350-60. Epub 2012 May 2.

Servicio de Bioquímica Clínica, Hospital Universitario Virgen Macarena, 41009 Sevilla, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2012.04.027DOI Listing
January 2013

Tag-SNP analysis of the GFI1-EVI5-RPL5-FAM69 risk locus for multiple sclerosis.

Eur J Hum Genet 2010 Jul 20;18(7):827-31. Epub 2010 Jan 20.

Instituto de Parasitología y Biomedicina López Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ejhg.2009.240DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987353PMC
July 2010

Hexose-6-phosphate dehydrogenase: a new risk gene for multiple sclerosis.

Eur J Hum Genet 2010 May 25;18(5):618-20. Epub 2009 Nov 25.

Department of Cell Biology and Immunology, Instituto de Parasitología y Biomedicina López Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/ejhg2009213
Publisher Site
http://dx.doi.org/10.1038/ejhg.2009.213DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987318PMC
May 2010

Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE.

Nat Immunol 2009 Sep 16;10(9):958-64. Epub 2009 Aug 16.

Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ni.1775DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746562PMC
September 2009